Seeking Alpha

Echo Therapeutics (ECTE +1.9%) says that its priced its full 4.628M share public offering, which...

Echo Therapeutics (ECTE +1.9%) says that its priced its full 4.628M share public offering, which includes the full over-allotment exercise, at $2.70 per share, an actual 3% premium to today's closing price of $2.62. Demand for the deal was high, and the sale will generate around $12.5M in gross proceeds before the underwriting discount and other offering costs are deducted. Shares +1.9% AH.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector